A systematic review of the use of economic evaluation in local decision-making

Health Policy
Oya Eddama, Joanna Coast

Abstract

In view of resource scarcity, decisions have to be made on the optimal allocation of resources and one possible option in health care is economic evaluation. Little is known, however, about the use of economic evaluation. The objectives of this review were to assimilate the empirical evidence on this topic, discuss the main findings, and explore the possible need for further work needed in this area. A total of 40 studies were included in the review from a range of countries. A systematic search strategy was used and data from papers were extracted in a systematic way. Pharmacists and clinicians in the US are the most frequently sampled group and postal surveys was the most commonly used method. Despite some positive findings, in most cases there appear to be obstacles to the extensive use of economic evaluation in decision-making. Obstacles can be linked to three factors: (1) institutional and political; (2) cultural; (3) methodological factors associated with economic evaluation itself. There has clearly been an increase in the use of economic evaluation over time, especially in the UK, whereas the US appears to have a deep rooted disfavour of the approach. However, there is still little known about the exact influence of eco...Continue Reading

References

May 1, 1996·Journal of General Internal Medicine·C A SteinerA Das
Aug 1, 1997·Social Science & Medicine·A LylesA M Rentz
Aug 1, 1997·Social Science & Medicine·M DrummondT Walley
Aug 1, 1997·Social Science & Medicine·B Jönsson
Feb 6, 1998·PharmacoEconomics·J A MauskopfA Stergachis
Jun 23, 2000·Health Policy·C Hoffmann, J M Graf von der Schulenburg
Nov 25, 2000·BMJ : British Medical Journal·P A SingerL Purdy
Dec 12, 2000·The Western Journal of Medicine·M E GinsburgW A Sandberg
Mar 29, 2002·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Christiane HoffmannMichael F Drummond
Aug 13, 2002·Journal of Health Services Research & Policy·Paul Johnstone, Prabha Lacey
Oct 19, 2002·BMJ : British Medical Journal·Cam DonaldsonCraig Mitton
Jan 25, 2003·Health Policy·David McDaidUNKNOWN ASTEC Group
Mar 18, 2003·Social Science & Medicine·Peter A UbelDavid A Asch
Apr 4, 2003·Health Affairs·Sheila LeathermanMaureen Bisognano
Jul 16, 2003·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Michael DrummondUNKNOWN ISPOR Task Force
Jan 8, 2004·Health Care Analysis : HCA : Journal of Health Philosophy and Policy·Craig Mitton, Cam Donaldson
Mar 3, 2004·Social Science & Medicine·K Neil Jenkings, Nick Barber
Aug 7, 2004·Journal of Interpersonal Violence·Grant T HarrisJoseph A Camilleri
Aug 12, 2004·Journal of Evaluation in Clinical Practice·Olivia WuNeil Craig
Nov 20, 2004·BMJ : British Medical Journal·Joanna Coast
May 13, 2006·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Giovanni Fattore, Aleksandra Torbica
Oct 28, 2006·PharmacoEconomics·Martin J Buxton
Oct 28, 2006·PharmacoEconomics·Peter J Neumann, Sean D Sullivan
Aug 19, 2007·Social Science & Medicine·Iestyn P Williams, Stirling Bryan

❮ Previous
Next ❯

Citations

Jul 27, 2012·British Medical Bulletin·Belén Corbacho, Jose Luis Pinto-Prades
Jun 2, 2011·BMC Health Services Research·Richard D HolmesCam Donaldson
Mar 12, 2011·Clinical Chemistry and Laboratory Medicine : CCLM·Massimo BrunettiTommaso Trenti
Dec 31, 2009·The British Journal of General Practice : the Journal of the Royal College of General Practitioners·Angelique T M Dierick-van DaeleHubertus J M Vrijhoef
Nov 3, 2012·Journal of Health Organization and Management·Neale SmithStuart Peacock
Aug 1, 2008·Expert Review of Pharmacoeconomics & Outcomes Research·Dominika Wranik
Mar 30, 2016·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Eman A Hammad
Oct 31, 2008·Health Economics·Neale SmithStuart Peacock
Jul 6, 2010·The British Journal of Surgery·M GomesUNKNOWN GALA Collaborative Group
Jan 18, 2013·Journal of Mental Health·Cathrine MihalopoulosTheo Vos
Jun 15, 2011·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Sandra Erntoft
Jan 1, 2011·Saudi Pharmaceutical Journal : SPJ : the Official Publication of the Saudi Pharmaceutical Society·Mohammed S Alsultan
Aug 15, 2014·Medical Decision Making : an International Journal of the Society for Medical Decision Making·Mara AiroldiGwyn Bevan
Aug 30, 2011·Australian Health Review : a Publication of the Australian Hospital Association·Abdolvahab BaghbanianFreidoon A Khavarpour
Apr 20, 2012·Australian Health Review : a Publication of the Australian Hospital Association·Abdolvahab BaghbanianFreidoon A Khavarpour
Jul 30, 2016·The International Journal of Health Planning and Management·W Dominika WranikAdrian Levy
Sep 2, 2017·Expert Review of Pharmacoeconomics & Outcomes Research·Chiara FeigSusanne Mayer
Apr 21, 2018·The International Journal of Health Planning and Management·Robyn LambertHossein Haji Ali Afzali
Sep 11, 2012·Australian Health Review : a Publication of the Australian Hospital Association·Abdolvahab Baghbanian, Ghazal Torkfar
May 19, 2019·Health Research Policy and Systems·Haniye Sadat SajadiJohn Lavis
Oct 30, 2010·Journal of Evaluation in Clinical Practice·Ties HoomansJohan L Severens
Feb 2, 2016·The Veterinary Quarterly·Yasuhiro FukuyamaTakuya Maruo
Sep 6, 2014·International Journal of Behavioral Medicine·Paul M BrownSteven Ramondt
Feb 15, 2013·Experimental and Therapeutic Medicine·Jingjing ZhangZhiqing Chen

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.